Dr Natalie Staplin
|Tel||+44 (0)1865 743975|
Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Sciences. She joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics. Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease. She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.
Storey BC. et al, (2017), Kidney Int
Biliary Tract and Liver Complications in Polycystic Kidney Disease.
Judge PK. et al, (2017), J Am Soc Nephrol, 28, 2738 - 2748
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.
Reith C. et al, (2017), BMC Nephrol, 18
Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP).
Staplin N. et al, (2017), Clin J Am Soc Nephrol, 12, 546 - 552
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease.
Herrington W. et al, (2017), Hypertension, 69, 314 - 322